These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16259219

  • 1. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
    Haluzik M.
    Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
    [Abstract] [Full Text] [Related]

  • 2. Adiponectin, obesity, and cardiovascular disease.
    Fasshauer M, Paschke R, Stumvoll M.
    Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
    [Abstract] [Full Text] [Related]

  • 3. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
    Kawano J, Arora R.
    J Cardiometab Syndr; 2009 Nov; 4(1):44-9. PubMed ID: 19245516
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [Abstract] [Full Text] [Related]

  • 5. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
    Owecki M, Sowiński J.
    Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
    [Abstract] [Full Text] [Related]

  • 6. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C, Park J, Park J, Kang E, Ahn C, Cha B, Lim S, Kim K, Lee H.
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [Abstract] [Full Text] [Related]

  • 7. [Research advancement of adipocytokine adiponectin].
    Xiao FY, Lu FE.
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):309-13. PubMed ID: 14992011
    [Abstract] [Full Text] [Related]

  • 8. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]

  • 9. Adiponectin, obesity and atherosclerosis.
    Behre CJ.
    Scand J Clin Lab Invest; 2007 Feb; 67(5):449-58. PubMed ID: 17763181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
    Tilg H, Moschen AR.
    Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
    [Abstract] [Full Text] [Related]

  • 13. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
    Achari AE, Jain SK.
    Int J Mol Sci; 2017 Jun 21; 18(6):. PubMed ID: 28635626
    [Abstract] [Full Text] [Related]

  • 14. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM, Olijhoek JK, Visseren FL.
    Eur J Clin Invest; 2007 Jan 21; 37(1):8-17. PubMed ID: 17181562
    [Abstract] [Full Text] [Related]

  • 15. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity].
    Bastarrachea RA, Montero JC, Saavedra-Gajardo I, Cerda-Flores R, Machado-Domínguez A, Comuzzie AG.
    Rev Med Chil; 2008 Jan 21; 136(1):107-17. PubMed ID: 18483661
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C, Fu Y, Chung BH, Garvey WT.
    Curr Opin Lipidol; 2007 Jun 21; 18(3):263-70. PubMed ID: 17495599
    [Abstract] [Full Text] [Related]

  • 17. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J, McQuillan BM, Thompson PL, Beilby JP.
    Int J Obes (Lond); 2008 May 21; 32(5):772-9. PubMed ID: 18253163
    [Abstract] [Full Text] [Related]

  • 18. Adiponectin in health and disease.
    Oh DK, Ciaraldi T, Henry RR.
    Diabetes Obes Metab; 2007 May 21; 9(3):282-9. PubMed ID: 17391153
    [Abstract] [Full Text] [Related]

  • 19. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T, Kadowaki T.
    Int J Obes (Lond); 2008 Dec 21; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [Abstract] [Full Text] [Related]

  • 20. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR, Fernández-Real JM, Richart C, Megía A, Gómez JM, Miranda M, Caubet E, Pastor R, Masdevall C, Vilarrasa N, Ricard W, Vendrell J.
    Obesity (Silver Spring); 2007 Mar 21; 15(3):664-72. PubMed ID: 17372317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.